Summary
Haemonetics Corporation (Haemonetics) is a healthcare company, which offers blood management technology and software solutions. The company’s portfolio consists of integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite of solutions to the blood supply chain, which ranges from plasma and blood collectors to hospitals. Haemonetics markets its products to blood collection groups and independent blood centers, national health organizations, hospital service providers, hospitals, group purchasing organizations, and bio-pharmaceutical companies through a direct sales force and independent distributors. It has subsidiaries in the Americas, Asia and Europe. Haemonetics is headquartered in Braintree, Massachusetts, the US.
Haemonetics Corporation (HAE) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Haemonetics Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Haemonetics Corporation, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Haemonetics Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Haemonetics Corporation, Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Haemonetics Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Haemonetics Corporation, Medical Equipment, Deal Details 11
Asset Purchase 11
Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For US$551 Million 11
Partnerships 13
HemaCare Enters Into Licensing Agreement With Haemonetics 13
Haemonetics Enters Into Licensing Agreement With Alba Bioscience 14
Cerus Enters into Agreement with Haemonetics 15
Acquisition 16
Haemonetics Completes Acquisition Of Hemerus Medical, Leukoreduction Technologies Provider, For Up To US$41 Million 16
Haemonetics Completes Tender Offer For Acquisition Of Global Med Technologies 18
Haemonetics Corporation - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 25
Financial Announcements 25
May 02, 2016: Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported 25
Feb 01, 2016: Haemonetics Reports 3rd Quarter Fiscal 2016 Revenue of $233 Million, Constant Currency Revenue Growth of 4% and 1% As Reported 29
Nov 04, 2015: Haemonetics Reports 2nd Quarter Fiscal 2016 Revenue of $220 Million and Adjusted EPS of $0.44, Affirms Recent Full Fiscal Year Guidance 32
Jul 27, 2015: Haemonetics Reports 1St Quarter Fiscal 2016 Revenue Of $213 Million and Adjusted Eps Of $0.35, Reaffirms Full Fiscal Year Guidance 36
Apr 27, 2015: Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; 40
Jan 29, 2015: Haemonetics Reports 3rd Quarter Fiscal 2015 Revenue of $232 Million and Adjusted EPS of $0.53; Reaffirms Revenue and EPS Guidance 44
Corporate Communications 48
Aug 01, 2016: Haemonetics Appoints Bill Burke CFO 48
May 09, 2016: Haemonetics Announces Christopher Simon as President and Chief Executive Officer 49
Apr 14, 2016: Haemonetics Announces CFO's Retirement 50
Sep 29, 2015: Haemonetics Corporation Appoints Ron Gelbman as Interim CEO; CEO Brian Concannon Resigns 51
Apr 27, 2015: Haemonetics Expands Executive Management Roles To Complement Global Growth Strategy 52
Government and Public Interest 53
Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 53
Other Significant Developments 55
May 09, 2016: Haemonetics Provides Fiscal 2017 Guidance 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
List Of Tables
List of Tables
Haemonetics Corporation, Medical Equipment, Key Facts, 2016 1
Haemonetics Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Haemonetics Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Haemonetics Corporation, Medical Equipment Deals By Type, 2010 to YTD 2016 7
Haemonetics Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Haemonetics Corporation, Deals By Market, 2010 to YTD 2016 9
Haemonetics Corporation, Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Haemonetics Completes Acquisition Of Blood Collection, Filtration And Processing Product Lines From Pall For US$551 Million 11
HemaCare Enters Into Licensing Agreement With Haemonetics 13
Haemonetics Enters Into Licensing Agreement With Alba Bioscience 14
Cerus Enters into Agreement with Haemonetics 15
Haemonetics Completes Acquisition Of Hemerus Medical, Leukoreduction Technologies Provider, For Up To US$41 Million 16
Haemonetics Completes Tender Offer For Acquisition Of Global Med Technologies 18
Haemonetics Corporation, Key Competitors 20
Haemonetics Corporation, Key Employees 21
Haemonetics Corporation, Other Locations 22
Haemonetics Corporation, Subsidiaries 22
List Of Figures
List of Figures
Haemonetics Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Haemonetics Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Haemonetics Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Haemonetics Corporation, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Haemonetics Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Haemonetics Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Haemonetics Corporation, Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Haemonetics Corporation, Medical Equipment, Deals by Market, 2010 to YTD 2016 9
